Form 4: Integra LifeSciences Director Keith Bradley Reports Transaction in Company Stock
SEC Form 4 Filing
Director Keith Bradley reports a transaction involving Integra LifeSciences Holdings Corp. stock, including the acquisition and disposal of shares.
Summary
- On May 9, 2025, Director Keith Bradley engaged in transactions involving Integra LifeSciences Holdings Corp. common stock.
- Bradley disposed of 392 shares at a price of $12.25.
- He also acquired 19,592 shares at a price of $0.
- Following these transactions, Bradley beneficially owns 89,136 shares of Integra LifeSciences Holdings Corp. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure related to insider trading regulations and provides transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date of stock transaction (disposal and acquisition). |
| 05/13/2025 | Date of signature for the power of attorney. |
Keywords
Form 4, Integra LifeSciences, Director, Keith Bradley, Stock Transaction, Beneficial Ownership, IART
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.